A project funded by the US FDA could lay the groundwork for potentially using real-world evidence instead of a clinical trial as part of a drug development strategy.
A group that includes Brigham and Women's Hospital, Harvard Medical School, and health care data company Aetion, is seeking to replicate the results of 30 randomized clinical trials using claims...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?